🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Sandoz GmbH — Licensed Medicines

65 medicines held by Sandoz GmbH on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 65 products held by Sandoz GmbH
MedicineActive substanceLicence holderStatus
Pregabalin Sandoz GmbH 225 mg hard capsules
EU/1/15/1012/063-068
Pregabalin Sandoz GmbH
Pregabalin Sandoz GmbH 25 mg hard capsules
EU/1/15/1012/001-010
Pregabalin Sandoz GmbH
Pregabalin Sandoz GmbH 300 mg hard capsules
EU/1/15/1012/069-083
Pregabalin Sandoz GmbH
Pregabalin Sandoz GmbH 50 mg hard capsules
EU/1/15/1012/011-017
Pregabalin Sandoz GmbH
Pregabalin Sandoz GmbH 75 mg hard capsules
EU/1/15/1012/018-033
Pregabalin Sandoz GmbH
Rixathon 100 mg concentrate for solution for infusion
EU/1/17/1185/001-002
Rituximab Sandoz GmbH
Rixathon 500 mg concentrate for solution for infusion
EU/1/17/1185/003-004
Rituximab Sandoz GmbH
Riximyo 100 mg concentrate for solution for infusion
EU/1/17/1184/001-002
Rituximab Sandoz GmbH
Riximyo 500 mg concentrate for solution for infusion
EU/1/17/1184/003-004
Rituximab Sandoz GmbH
Rolcya 60 mg solution for injection in pre-filled syringe
EU/1/25/1958/001
Denosumab Sandoz GmbH
Wyost 120 mg solution for injection
EU/1/24/1812/001
Denosumab Sandoz GmbH
Zarzio 30 MU (60 MU/ml) Solution for injection or
EU/1/08/495/1-4,9-12
Ep2006 (recombinant human granulocyte-colony stimulating factor) Sandoz GmbH
Zarzio 48 MU (96 MU/ml) Solution for injection or
EU/1/08/495/5-8,13-16
Ep2006 (recombinant human granulocyte-colony stimulating factor) Sandoz GmbH
Zessly 100 mg powder for concentrate for solution for infusion
EU/1/18/1280/001-005
Infliximab Sandoz GmbH
Ziextenzo 6 mg solution for injection in pre-filled syringe
EU/1/18/1327/001
Pegfilgrastim Sandoz GmbH
1 2
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 7 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.